History
Advanced Accelerator Applications was founded in 2002 by physicist Stefano Buono, who was inspired to pursue medical applications for certain research conducted during his tenure at the European Organization for Nuclear Research, or CERN, with Nobel laureate Carlo Rubbia.
Advanced Accelerator Applications Founded
First Cyclotron Built in France
EMA approval of Gluscan 500
Obtained the rights to develop and commercialize Lutathera®
Listed on NASDAQ
FDA approval of NETSPOT® and EMA approval of SomaKit TOC®
Acquired by Novartis
FDA approval of Lutathera®
Endocyte acquisition
EMA approval of LysaKare®
Ivrea RLT site line expansion
Saint-Genis Pouilly Molecular Imaging site line expansion
FDA and EMA approval of Pluvicto® and Locametz®
Completion of new RLT site in Indianapolis, US
Start of construction of Molecular Imaging site in Salamanca
Announced plans to build RLT manufacturing capabilities in Sasayama, Japan and Haiyan, Zhejiang, China